{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:00:40Z","timestamp":1790992840410,"version":"4.1.0"},"reference-count":50,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2020,6,9]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Bipolar Disorder (BD) is a chronic a multifactorial psychiatric illness that affects mood,\ncognition, and functioning. BD is associated with several psychiatric conditions as well clinical\ncomorbidities, particularly cardiovascular diseases. The neurobiology of BD is complex and\nmultifactorial and several systems have been implicated. Considering that the Renin Angiotensin\nSystem (RAS) plays an important role in cardiovascular diseases and that recently evidence has\nsuggested its role in psychiatric disorders, the aim of the present study is to summarize and to\ndiscuss recent findings related to the modulation of RAS components in BD. A systematic search of\nthe literature using the electronic databases MEDLINE and LILACS was conducted through March\n2019. The search terms were: \u201cBipolar Disorder\u201d; \u201cRenin Angiotensin System\u201d; \u201cAngiotensin 2\u201d;\n\u201cAngiotensin receptors\u201d; \u201cAngiotensin 1-7\u201d; \u201cACE\u201d; \u201cACE2\u201d; \u201cMas Receptor\u201d. We included\noriginal studies assessing RAS in BD patients. Two hundred twenty-two citations were initially\nretrieved. Eleven studies were included in our systematic review. In the majority of studies (6 of 8),\nthe ACE insertion\/deletion (I\/D) polymorphism did not differ between BD patients and controls.\nBD patients presented higher plasma renin activity in comparison with controls. The studies\nevaluating the RAS molecules in BD are very scarce and heterogeneous. The literature suggests a\npotential role of RAS in BD. Further studies are necessary to investigate this relationship.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929866527666200127115059","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T14:34:55Z","timestamp":1580135695000},"page":"520-528","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Renin Angiotensin System and Bipolar Disorder: A Systematic Review"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4480-0195","authenticated-orcid":true,"given":"Izabela Guimar\u00e3es","family":"Barbosa","sequence":"first","affiliation":[{"name":"Interdisciplinary Laboratory of Medical Investigation - Faculty of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4317-832X","authenticated-orcid":true,"given":"Giulia Campos","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Interdisciplinary Laboratory of Medical Investigation - Faculty of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4984-7187","authenticated-orcid":true,"given":"Diomildo Ferreira","family":"Andrade J\u00fanior","sequence":"additional","affiliation":[{"name":"Interdisciplinary Laboratory of Medical Investigation - Faculty of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5530-2730","authenticated-orcid":true,"given":"C\u00e1ssio Rocha","family":"Janu\u00e1rio","sequence":"additional","affiliation":[{"name":"Interdisciplinary Laboratory of Medical Investigation - Faculty of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0166-4258","authenticated-orcid":true,"given":"Andr\u00e9 Rolim","family":"Belis\u00e1rio","sequence":"additional","affiliation":[{"name":"Interdisciplinary Laboratory of Medical Investigation - Faculty of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2957-1352","authenticated-orcid":true,"given":"Moises Evandro","family":"Bauer","sequence":"additional","affiliation":[{"name":"Laboratory of Immunosenescence, Graduate Program in Biomedical Gerontology, School of Sciences, Pontif\u00edcia Universidade Catolica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9222-3882","authenticated-orcid":true,"given":"Ana Cristina","family":"Sim\u00f5es e Silva","sequence":"additional","affiliation":[{"name":"Interdisciplinary Laboratory of Medical Investigation - Faculty of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/2045125318769235","volume":"8","author":"Rowland T.A.","year":"2018","unstructured":"Rowland T.A.; Marwaha S.; Epidemiology and risk factors for bipolar disorder. Ther Adv Psychopharmacol 2018,8(9),251-269","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","volume":"68","author":"Merikangas K.R.","year":"2011","unstructured":"Merikangas K.R.; Jin R.; He J.P.; Kessler R.C.; Lee S.; Sampson N.A.; Viana M.C.; Andrade L.H.; Hu C.; Karam E.G.; Ladea M.; Medina-Mora M.E.; Ono Y.; Posada-Villa J.; Sagar R.; Wells J.E.; Zarkov Z.; Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011,68(3),241-251","journal-title":"Arch Gen Psychiatry"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/bdi.12423","volume":"18","author":"Ferrari A.J.","year":"2016","unstructured":"Ferrari A.J.; Stockings E.; Khoo J.P.; Erskine H.E.; Degenhardt L.; Vos T.; Whiteford H.A.; The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013. Bipolar Disord 2016,18(5),440-450","journal-title":"Bipolar Disord"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/bdi.12609","volume":"20","author":"Yatham L.N.","year":"2018","unstructured":"Yatham L.N.; Kennedy S.H.; Parikh S.V.; Schaffer A.; Bond D.J.; Frey B.N.; Sharma V.; Goldstein B.I.; Rej S.; Beaulieu S.; Alda M.; MacQueen G.; Milev R.V.; Ravindran A.; O\u2019Donovan C.; McIntosh D.; Lam R.W.; Vazquez G.; Kapczinski F.; McIntyre R.S.; Kozicky J.; Kanba S.; Lafer B.; Suppes T.; Calabrese J.R.; Vieta E.; Malhi G.; Post R.M.; Berk M.; Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord 2018,20(2),97-170","journal-title":"Bipolar Disord"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/archpsyc.60.3.261","volume":"60","author":"Judd L.L.","year":"2003","unstructured":"Judd L.L.; Akiskal H.S.; Schettler P.J.; Coryell W.; Endicott J.; Maser J.D.; Solomon D.A.; Leon A.C.; Keller M.B.; A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003,60(3),261-269","journal-title":"Arch Gen Psychiatry"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/archpsyc.58.9.844","volume":"58","author":"Osby U.","year":"2001","unstructured":"Osby U.; Brandt L.; Correia N.; Ekbom A.; Spar\u00e9n P.; Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001,58(9),844-850","journal-title":"Arch Gen Psychiatry"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/07853890.2012.687835","volume":"45","author":"Calkin C.V.","year":"2013","unstructured":"Calkin C.V.; Gardner D.M.; Ransom T.; Alda M.; The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders. Ann Med 2013,45(2),171-181","journal-title":"Ann Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s11920-012-0313-8","volume":"14","author":"McElroy S.L.","year":"2012","unstructured":"McElroy S.L.; Keck P.E.; Obesity in bipolar disorder: an overview. Curr Psychiatry Rep 2012,14(6),650-658","journal-title":"Curr Psychiatry Rep"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jad.2014.08.052","volume":"170","author":"Perugi G.","year":"2015","unstructured":"Perugi G.; Quaranta G.; Belletti S.; Casalini F.; Mosti N.; Toni C.; Dell\u2019Osso L.; General medical conditions in 347 bipolar disorder patients: clinical correlates of metabolic and autoimmune-allergic diseases. J Affect Disord 2015,170,95-103","journal-title":"J Affect Disord"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/brainsci7110144","volume":"30","author":"Rosenblat J.D.","year":"2017","unstructured":"Rosenblat J.D.; McIntyre R.S.; Bipolar disorder and immune dysfunction: Epidemiological findings, proposed pathophysiology and clinical implications. Brain Sci 2017,30(7),144","journal-title":"Brain Sci"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/360481","volume":"2014","author":"Barbosa I.G.","year":"2014","unstructured":"Barbosa I.G.; Bauer M.E.; Machado-Vieira R.; Teixeira A.L.; Cytokines in bipolar disorder: paving the way for neuroprogression. Neural Plast 2014,2014","journal-title":"Neural Plast"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1080\/14737159.2016.1248413","volume":"16","author":"Teixeira A.L.","year":"2016","unstructured":"Teixeira A.L.; Salem H.; Frey B.N.; Barbosa I.G.; Machado-Vieira R.; Update on bipolar disorder biomarker candidates. Expert Rev Mol Diagn 2016,16(11),1209-1220","journal-title":"Expert Rev Mol Diagn"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","volume":"47","author":"Munkholm K.","year":"2013","unstructured":"Munkholm K.; Bra\u00fcner J.V.; Kessing L.V.; Vinberg M.; Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res 2013,47(9),1119-1133","journal-title":"J Psychiatr Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1152\/physrev.1977.57.2.313","volume":"57","author":"Peach M.J.","year":"1977","unstructured":"Peach M.J.; Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 1977,57(2),313-370","journal-title":"Physiol Rev"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1365-2796.2008.01981.x","volume":"264","author":"Fyhrquist F.","year":"2008","unstructured":"Fyhrquist F.; Saijonmaa O.; Renin-angiotensin system revisited. J Intern Med 2008,264(3),224-236","journal-title":"J Intern Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1161\/01.RES.0000148637.85595.c5","volume":"95","author":"Kazama K.","year":"2004","unstructured":"Kazama K.; Anrather J.; Zhou P.; Girouard H.; Frys K.; Milner T.A.; Iadecola C.; Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res 2004,95(10),1019-1026","journal-title":"Circ Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00109-008-0331-5","volume":"86","author":"Phillips M.I.","year":"2008","unstructured":"Phillips M.I.; de Oliveira E.M.; Brain renin angiotensin in disease. J Mol Med (Berl) 2008,86(6),715-722","journal-title":"J Mol Med (Berl)"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/1470320315583582","volume":"16","author":"Kalra J.","year":"2015","unstructured":"Kalra J.; Prakash A.; Kumar P.; Majeed A.B.A.; Cerebroprotective effects of RAS inhibitors: Beyond their cardio-renal actions. J Renin Angiotensin Aldosterone Syst 2015,16(3),459-468","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2174\/138161212799436593","volume":"18","author":"Capettini L.S.","year":"2012","unstructured":"Capettini L.S.; Montecucco F.; Mach F.; Stergiopulos N.; Santos R.A.; da Silva R.F.; Role of renin-angiotensin system in inflammation, immunity and aging. Curr Pharm Des 2012,18(7),963-970","journal-title":"Curr Pharm Des"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s00467-011-2002-y","volume":"27","author":"Sim\u00f5es E Silva A.C.","year":"2012","unstructured":"Sim\u00f5es E Silva A.C.; Flynn J.T.; The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease. Pediatr Nephrol 2012,27(10),1835-1845","journal-title":"Pediatr Nephrol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2174\/1389450117666160727142401","volume":"18","author":"Rodrigues Prestes T.R.","year":"2017","unstructured":"Rodrigues Prestes T.R.; Rocha N.P.; Miranda A.S.; Teixeira A.L.; Simoes-E-Silva A.C.; The anti-inflammatory potential of ACE2\/angiotensin-(1-7)\/Mas receptor axis: Evidence from basic and clinical research. Curr Drug Targets 2017,18(11),1301-1313","journal-title":"Curr Drug Targets"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"Donoghue M.","year":"2000","unstructured":"Donoghue M.; Hsieh F.; Baronas E.; Godbout K.; Gosselin M.; Stagliano N.; Donovan M.; Woolf B.; Robison K.; Jeyaseelan R.; Breitbart R.E.; Acton S.; A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000,87(5),E1-E9","journal-title":"Circ Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"33238","DOI":"10.1074\/jbc.M002615200","volume":"275","author":"Tipnis S.R.","year":"2000","unstructured":"Tipnis S.R.; Hooper N.M.; Hyde R.; Karran E.; Christie G.; Turner A.J.; A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000,275(43),33238-33243","journal-title":"J Biol Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1073\/pnas.85.11.4095","volume":"85","author":"Schiavone M.T.","year":"1988","unstructured":"Schiavone M.T.; Santos R.A.; Brosnihan K.B.; Khosla M.C.; Ferrario C.M.; Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci USA 1988,85(11),4095-4098","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/0196-9781(88)90208-2","volume":"9","author":"Block C.H.","year":"1988","unstructured":"Block C.H.; Santos R.A.; Brosnihan K.B.; Ferrario C.M.; Immunocytochemical localization of angiotensin-(1-7) in the rat forebrain. Peptides 1988,9(6),1395-1401","journal-title":"Peptides"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"8258","DOI":"10.1073\/pnas.1432869100","volume":"100","author":"Santos R.A.S.","year":"2003","unstructured":"Santos R.A.S.; Simoes e Silva A.C.; Maric C.; Silva D.M.R.; Machado R.P.; de Buhr I.; Heringer-Walther S.; Pinheiro S.V.B.; Lopes M.T.; Bader M.; Mendes E.P.; Lemos V.S.; Campagnole-Santos M.J.; Schultheiss H.P.; Speth R.; Walther T.; Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 2003,100(14),8258-8263","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD201501","volume":"10","author":"Chandler J.","year":"2015","unstructured":"Chandler J.; McKenzie J.; Boutron I.; Welch V.; Cochrane methods. Cochrane DB Syst Rev 2015,10(Suppl. 1),1-72","journal-title":"Cochrane DB Syst Rev"},{"key":"ref=28","author":"Wells G.A.","unstructured":"Wells G.A.; Shea B.; O\u2019Connell D.; Peterson J.; Welch V.; Losos M.; Tugwell P.;  The Newcastle-Ottawa Scale (NOS) for\n  assessing the quality of nonrandomized studies in meta-analysis,\n  2019. Available from:\n                     ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\">http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/YPG.0b013e3283351194","volume":"20","author":"Kucukali C.I.","year":"2010","unstructured":"Kucukali C.I.; Aydin M.; Ozkok E.; Bilge E.; Zengin A.; Cakir U.; Kara I.; Angiotensin-converting enzyme polymorphism in schizophrenia, bipolar disorders, and their first-degree relatives. Psychiatr Genet 2010,20(1),14-19","journal-title":"Psychiatr Genet"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ajmg.b.30784","volume":"150B","author":"Heck A.","year":"2009","unstructured":"Heck A.; Lieb R.; Ellgas A.; Pfister H.; Lucae S.; Erhardt A.; Himmerich H.; Horstmann S.; Kloiber S.; Ripke S.; M\u00fcller-Myhsok B.; Bettecken T.; Uhr M.; Holsboer F.; Ising M.; Polymorphisms in the angiotensin-converting enzyme gene region predict coping styles in healthy adults and depressed patients. Am J Med Genet B Neuropsychiatr Genet 2009,150B(1),104-114","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1440-1614.2006.01873.x","volume":"40","author":"Konuk N.","year":"2006","unstructured":"Konuk N.; Atik L.; Simsekyilmaz O.; Dursun A.; Acikgoz S.; Association of angiotensin converting enzyme gene polymorphism and affective disorders in Turkish patients. Aust N Z J Psychiatry 2006,40(8),717-718","journal-title":"Aust N Z J Psychiatry"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1017\/S1461145705005444","volume":"8","author":"Mendlewicz J.","year":"2005","unstructured":"Mendlewicz J.; Oswald P.; Claes S.; Massat I.; Souery D.; Van Broeckhoven C.; Del-Favero J.; Patient-control association study of substance P-related genes in unipolar and bipolar affective disorders. Int J Neuropsychopharmacol 2005,8(4),505-513","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s007020070023","volume":"107","author":"Pauls J.","year":"2000","unstructured":"Pauls J.; Bandelow B.; R\u00fcther E.; Kornhuber J.; Polymorphism of the gene of angiotensin converting enzyme: lack of association with mood disorder. J Neural Transm (Vienna) 2000,107(11),1361-1366","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0304-3940(00)01512-3","volume":"293","author":"Meira-Lima I.V.","year":"2000","unstructured":"Meira-Lima I.V.; Pereira A.C.; Mota G.F.; Krieger J.E.; Vallada H.; Angiotensinogen and angiotensin converting enzyme gene polymorphisms and the risk of bipolar affective disorder in humans. Neurosci Lett 2000,293(2),103-106","journal-title":"Neurosci Lett"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/1096-8628(20001204)96:6<733:AID AJMG7>3.0.CO;2-8","volume":"96","author":"Furlong R.A.","year":"2000","unstructured":"Furlong R.A.; Keramatipour M.; Ho L.W.; Rubinsztein J.S.; Michael A.; Walsh C.; Paykel E.S.; Rubinsztein D.C.; No association of an insertion\/deletion polymorphism in the angiotensin I converting enzyme gene with bipolar or unipolar affective disorders. Am J Med Genet 2000,96(6),733-735","journal-title":"Am J Med Genet"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/S0006-3223(95)00597-8","volume":"40","author":"Arinami T.","year":"1996","unstructured":"Arinami T.; Li L.; Mitsushio H.; Itokawa M.; Hamaguchi H.; Toru M.; An insertion\/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders. Biol Psychiatry 1996,40(11),1122-1127","journal-title":"Biol Psychiatry"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1192\/bjp.153.2.205","volume":"153","author":"Stewart P.M.","year":"1988","unstructured":"Stewart P.M.; Atherden S.M.; Stewart S.E.; Whalley L.; Edwards C.R.; Padfield P.L.; Lithium carbonate--a competitive aldosterone antagonist? Br J Psychiatry 1988,153,205-207","journal-title":"Br J Psychiatry"},{"key":"ref=38","doi-asserted-by":"publisher","author":"Altamura A.C.","unstructured":"Altamura A.C.; Morganti A.; Smeraldi E.; Zanchetti A.; lasma\n  renin activity in primary and secondary depression. Arch.\n  Psychiatr. Nervenkr. (1970), 1977, 224(4), 313-318.","DOI":"10.1007\/BF00341613"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/BF00429057","volume":"45","author":"Altamura A.C.","year":"1975","unstructured":"Altamura A.C.; Morganti A.; Plasma renin activity in depressed patients treated with increasing doses of lithium carbonate. Psychopharmacology (Berl) 1975,45(2),171-175","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI114844","volume":"86","author":"Rigat B.","year":"1990","unstructured":"Rigat B.; Hubert C.; Alhenc-Gelas F.; Cambien F.; Corvol P.; Soubrier F.; An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990,86(4),1343-1346","journal-title":"J Clin Invest"},{"key":"ref=41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046495","volume":"7","author":"Zhang Z.","year":"2012","unstructured":"Zhang Z.; Xu G.; Liu D.; Fan X.; Zhu W.; Liu X.; Angiotensin-converting enzyme insertion\/deletion polymorphism contributes to ischemic stroke risk: a meta-analysis of 50 case-control studies. PLoS One 2012,7(10)","journal-title":"PLoS One"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0272-6386(04)00816-9","volume":"44","author":"Ishimitsu T.","year":"2004","unstructured":"Ishimitsu T.; Tsukada K.; Ohta S.; Inada H.; Minami J.; Ono H.; Matsuoka H.; Increased cardiovascular risk in long-term hemodialysis patients carrying deletion allele of ACE gene polymorphism. Am J Kidney Dis 2004,44(3),466-475","journal-title":"Am J Kidney Dis"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"6895","DOI":"10.4238\/2013.December.19.8","volume":"12","author":"Guney A.I.","year":"2013","unstructured":"Guney A.I.; Ergec D.; Kirac D.; Ozturhan H.; Caner M.; Koc G.; Kaspar C.; Ulucan K.; Agirbasli M.; Effects of ACE polymorphisms and other risk factors on the severity of coronary artery disease. Genet Mol Res 2013,12(4),6895-6906","journal-title":"Genet Mol Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1161\/CIR.0000000000000229","volume":"132","author":"Goldstein B.I.","year":"2015","unstructured":"Goldstein B.I.; Carnethon M.R.; Matthews K.A.; McIntyre R.S.; Miller G.E.; Raghuveer G.; Stoney C.M.; Wasiak H.; McCrindle B.W.; American Heart Association Atherosclerosis; Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: A scientific statement from the American Heart Association. Circulation 2015,132(10),965-986","journal-title":"Circulation"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jad.2018.02.005","volume":"234","author":"Mistry S.","year":"2018","unstructured":"Mistry S.; Harrison J.R.; Smith D.J.; Escott-Price V.; Zammit S.; The use of polygenic risk scores to identify phenotypes associated with genetic risk of bipolar disorder and depression: A systematic review. J Affect Disord 2018,234,148-155","journal-title":"J Affect Disord"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/acps.12408","volume":"131","author":"Hayes J.F.","year":"2015","unstructured":"Hayes J.F.; Miles J.; Walters K.; King M.; Osborn D.P.; A systematic review and meta-analysis of premature mortality in bipolar affective disorder. Acta Psychiatr Scand 2015,131(6),417-425","journal-title":"Acta Psychiatr Scand"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.cjca.2017.10.006","volume":"33","author":"Goldstein B.I.","year":"2017","unstructured":"Goldstein B.I.; Bipolar disorder and the vascular system: Mechanisms and new prevention opportunities. Can J Cardiol 2017,33(12),1565-1576","journal-title":"Can J Cardiol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.krcp.2016.07.004","volume":"35","author":"Bhandari S.K.","year":"2016","unstructured":"Bhandari S.K.; Batech M.; Shi J.; Jacobsen S.J.; Sim J.J.; Plasma renin activity and risk of cardiovascular and mortality outcomes among individuals with elevated and nonelevated blood pressure. Kidney Res Clin Pract 2016,35(4),219-228","journal-title":"Kidney Res Clin Pract"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.2174\/0929867325666180226102358","volume":"25","author":"Rocha N.P.","year":"2018","unstructured":"Rocha N.P.; Simoes E Silva A.C.; Prestes T.R.R.; Feracin V.; Machado C.A.; Ferreira R.N.; Teixeira A.L.; de Miranda A.S.; RAS in the Central Nervous System: Potential Role in Neuropsychiatric Disorders. Curr Med Chem 2018,25(28),3333-3352","journal-title":"Curr Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12916-017-0916-3","volume":"15","author":"Vian J.","year":"2017","unstructured":"Vian J.; Pereira C.; Chavarria V.; K\u00f6hler C.; Stubbs B.; Quevedo J.; Kim S.W.; Carvalho A.F.; Berk M.; Fernandes B.S.; The renin-angiotensin system: a possible new target for depression. BMC Med 2017,15(1),144","journal-title":"BMC Med"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/178630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T04:17:31Z","timestamp":1596341851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/178630\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929866527666200127115059","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-07-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}